Issues related to support for domestic pharmaceutical manufacturing and the BIOSECURE Act; Issues related to S.Amdt.3236 to National Defense Authorization Act for Fiscal Year 2026 (S. 2296).
Literal federal measure citations: S. 2296
2025 · 3rd Quarter (July 1 - Sep 30)
Filed by AKIN GUMP STRAUSS HAUER & FELD.
Open official filingSource-reported fields
Literal source text
Issues related to support for domestic pharmaceutical manufacturing and the BIOSECURE Act; Issues related to S.Amdt.3236 to National Defense Authorization Act for Fiscal Year 2026 (S. 2296).
Literal federal measure citations: S. 2296
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.